Tenet Healthcare Corporation (THC) Q4 2025 Earnings Call Summary

1Key Financial Results and Metrics

Net Operating Revenues: $21.3 billion for the full year 2025.

Consolidated Adjusted EBITDA: $4.57 billion, a 14% increase from 2024, with a margin of 21.4%, up 210 basis points year-over-year.

Q4 Results:

Net Operating Revenues: $5.5 billion.

Adjusted EBITDA: $1.183 billion, a 13% increase year-over-year.

Adjusted EBITDA margin: 21.4%.

USPI Segment: Adjusted EBITDA grew 12% to $2.026 billion, with same-facility revenues up 7.5%.

Free Cash Flow: $367 million in Q4 and $2.53 billion for the full year.

Share Repurchases: Approximately 22% of outstanding shares repurchased since 2022 for around $2.5 billion.

2Strategic Updates and Business Highlights

M&A Activity: Invested nearly $350 million in 2025, adding 35 facilities, with a strong pipeline for future growth.

Hospital Segment: Adjusted EBITDA increased 16% to $2.54 billion, with same-store revenues per adjusted admission up 5.3%.

Operational Improvements: Focus on high acuity services and disciplined cost control contributed to strong performance.

Technology Investments: Emphasis on structural expense management through technology and automation to enhance efficiency.

3Forward Guidance and Outlook

2026 Adjusted EBITDA Guidance: Projected between $4.485 billion and $4.785 billion, driven by demand strength and service line expansion.

USPI EBITDA Guidance: Expected between $2.13 billion and $2.23 billion.

Hospital Segment EBITDA Guidance: Anticipated between $2.355 billion and $2.555 billion, factoring in headwinds from the expiration of enhanced premium tax credits.

Revenue Growth: Consolidated net operating revenues projected between $21.5 billion and $22.3 billion for 2026.

4Bad News, Challenges, or Points of Concern

Enrollment Decline: Anticipated 20% reduction in overall enrollment due to the expiration of enhanced premium tax credits, particularly affecting states with significant exposure.

Hospital Volume Growth: Projected growth of 1% to 2% in 2026, slower than previous years, influenced by the expiration of tax credits and overall market conditions.

Uncertainty in Payer Mix: Potential increase in uninsured rates and challenges in maintaining favorable payer mix as patients transition from exchange plans.

Operational Risks: Need for continued focus on cost management and efficiency improvements amid a changing healthcare landscape.

5Notable Q&A Insights

Hospital Volume Performance: Q4 same-store hospital admissions were flat, attributed to a weaker respiratory season.

Expense Management Strategy: Focus on structural changes rather than traditional annual cost-cutting, leveraging technology for sustainable efficiencies.

Impact of Exchange Programs: Management acknowledged uncertainty regarding the effect of enrollment changes on future volumes and revenues.

Conifer Transaction: The recent Conifer deal was framed as a strategic move to enhance future growth and control, with significant financial benefits anticipated.

USPI Growth Opportunities: Continued focus on higher acuity procedures and expansion into new service lines, particularly in response to changes in inpatient-only lists. This summary encapsulates Tenet Healthcare's financial performance, strategic direction, and outlook while highlighting potential challenges and insights from the earnings call.